Stanley W. Jacob (January 7, 1924 - February 6, 2015) was an American surgeon specializing in Organ transplantation. In the 1960 as head of the organ transplant team at Oregon Health & Science University he discovered tremendous advantages to using Dimethyl sulfoxide (also known as DMSO) for the preservation of organ transplant tissue.[1] Dr. Jacob spent much of his career researching Dimethyl Sulfoxide and advocating for its approval as a safe and effective medication. He was appointed the Gerlinger Professor of the Department of Surgery at OHSU in 1981 [2] He wrote and edited many books and papers on DMSO and was a book reviewer for JAMA (The Journal of the American Medical Association) until his death.
Stanley Jacob | |
|---|---|
| Born | January 7, 1924 Chicago, Illinois, U.S. |
| Died | January 17, 2015 (aged 91) |
Jacob was an Army Colonel and served in the Korean War as a Captain (armed forces)[3]
See also
edit"Dr. Stanley W. Jacob M.D and DMSO". DMSO Canada. 18 April 2018.
References
edit- ^ "About Dr. Stanley Jacob". DMSO.org. 18 April 2018.
- ^ "Dr. Stanley W. Jacob's biography, credentials, and achievements". Kala Health Inc.
- ^ "About Dr. Stanley Jacob". DMSO.org.